Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

29.67 +0.67 (+2.31%)

Official Closing Price Updated: 7:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

61 62 Next >

Why Hims & Hers Health (HIMS) Stock Is Trading Up Today

September 10, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 3.8% in the afternoon session after the company announced its long-awaited entry into the testosterone replacement therapy market.

Via StockStory

Hims & Hers Stock Jumps On Long-Awaited Foray Into Testosterone ↗

September 10, 2025

The company is making a move into a highly anticipated area and partnering with a privately held pharmaceutical company.

Via Investor's Business Daily

Topics ETFs

Hims & Hers Bets On Hormonal Health To Revive Investor Confidence ↗

September 10, 2025

Hims & Hers is entering the hormonal health market with low testosterone treatments for men, aiming to expand its services as weight-loss drug sales slow and investor interest grows.

Via Benzinga

Hims Launches New Category in Men’s Health with Exclusive Branded Oral Testosterone and Expanded Personalized Treatments

September 10, 2025

From Hims & Hers

Via Business Wire

Hims & Hers To Launch Low Testosterone Treatments for Men As Weight-Loss Drug Sales Slow ↗

September 09, 2025

The telehealth company is expanding into hormonal health with plans to eventually add therapies for women in perimenopause and menopause.

Via Stocktwits

10 Health Care Stocks Whale Activity In Today's Session ↗

September 09, 2025

Via Benzinga

Why Hims & Hers Health (HIMS) Stock Is Up Today

September 04, 2025

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 4.9% in the morning session after it continued a rally from the previous day fueled by strong revenue guidance and supportive analyst...

Via StockStory

Topics ETFs Economy

4 Top Stocks to Buy in September ↗

September 04, 2025

Here are four stocks to buy now that could offer investors upside in both the short and long term.

Via The Motley Fool

Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday ↗

September 03, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

September 02, 2025

Via Benzinga

EXCLUSIVE: August's 20 Most-Searched Tickers On Benzinga Pro – Where Do Opendoor, Palantir, BitMine Immersion, Apple Stock Rank? ↗

September 02, 2025

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.

Via Benzinga

HIMS & HERS ALERT: Bragar Eagel & Squire, P.C. is Investigating Hims & Hers Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

August 27, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Rocket, Oscar, Hims & Hers: Short Sellers Are Playing With Fire ↗

August 25, 2025

Hims & Hers, which boasts a $9.7 billion market cap, is up 170% over the past year, though it's pulled back nearly 25% this past month.

Via Benzinga

Discounted Ozempic Could Deflate ETF Optimism Around Hims & Hers ↗

August 25, 2025

Hims & Hers investors hit with more bad news as Novo Nordisk partners with GoodRx to offer discounted access to competing products. ETFs with high concentration in HIMS may face risks and losses.

Via Benzinga

Topics ETFs

HIMS FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the August 25th Deadline for the Hims Lawsuit and Urges Investors to Contact The Firm

August 25, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health

August 25, 2025

From Faruqi & Faruqi, LLP

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS

August 25, 2025

From Pomerantz LLP

Via GlobeNewswire

Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Seeking Recovery for Investors - Contact Levi & Korsinsky

August 25, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Seeking Recovery for Investors - Contact Levi & Korsinsky

August 25, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Deadline is August 25, 2025 to Lead in Securities Class Action Against Hims & Hers Health, Inc. (HIMS) - Contact Kaplan Fox

August 23, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Deadline is August 25, 2025 to Lead in Securities Class Action Against Hims & Hers Health, Inc. (HIMS) - Contact Kaplan Fox

August 23, 2025

Via TheNewswire.com

Topics Lawsuit

HIMS & HERS HEALTH 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS

August 22, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Deadline to Lead in Securities Class Action Against Hims & Hers Health, Inc. (HIMS) is August 25, 2025 - Contact Kaplan Fox

August 22, 2025

Via TheNewswire.com

Topics Lawsuit

Deadline to Lead in Securities Class Action Against Hims & Hers Health, Inc. (HIMS) is August 25, 2025 - Contact Kaplan Fox

August 22, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

MONDAY DEADLINE: Berger Montague Advises Hims & Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Class Action by August 25, 2025

August 22, 2025

From Berger Montague

Via GlobeNewswire

Class Action Filed Against Hims & Hers Health, Inc. (HIMS) - August 25, 2025 Deadline to Join - Contact Levi & Korsinsky

August 22, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Class Action Filed Against Hims & Hers Health, Inc. (HIMS) - August 25, 2025 Deadline to Join - Contact Levi & Korsinsky

August 22, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Healthcare Technology Stocks Q2 Highlights: Hims & Hers Health (NYSE:HIMS)

August 21, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at healthcare technology stocks, starting...

Via StockStory

Defiance Rolls Out Leveraged ETFs Targeting AMD, Supermicro, Palantir, Hims & Robinhood ↗

August 21, 2025

Defiance ETFs introduces 5 new leveraged ETFs providing magnified exposure to popular tech, healthcare, and retail stocks, with a mix of growth and income.

Via Benzinga

Topics ETFs

HIMS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the August 25th Deadline for the Hims Lawsuit and Urges Investors to Contact The Firm

August 21, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

61 62 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.